313.04
Zscaler Inc stock is traded at $313.04, with a volume of 1.12M.
It is up +1.02% in the last 24 hours and up +10.54% over the past month.
Zscaler is a software-as-a-service, or SaaS, firm focusing on providing cloud-native cybersecurity solutions to primarily enterprise customers. Zscaler's offerings can be broadly partitioned into Zscaler Internet Access, which provides secure access to external applications, and Zscaler Private Access, which provides secure access to internal applications. The firm is headquartered in San Jose, California, and went public in 2018.
See More
Previous Close:
$309.88
Open:
$315
24h Volume:
1.12M
Relative Volume:
0.70
Market Cap:
$49.55B
Revenue:
$2.67B
Net Income/Loss:
$-41.48M
P/E Ratio:
-1,167.19
EPS:
-0.2682
Net Cash Flow:
$726.69M
1W Performance:
+2.56%
1M Performance:
+10.54%
6M Performance:
+58.04%
1Y Performance:
+57.89%
Zscaler Inc Stock (ZS) Company Profile
Name
Zscaler Inc
Sector
Industry
Phone
(408) 533-0288
Address
120 HOLGER WAY, SAN JOSE, CA
Compare ZS with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
ZS
Zscaler Inc
|
313.04 | 49.05B | 2.67B | -41.48M | 726.69M | -0.2682 |
![]()
MSFT
Microsoft Corporation
|
514.05 | 3.80T | 281.72B | 101.83B | 71.61B | 13.64 |
![]()
ORCL
Oracle Corp
|
308.01 | 835.17B | 59.02B | 12.63B | -5.88B | 4.3198 |
![]()
PLTR
Palantir Technologies Inc
|
177.21 | 416.20B | 3.44B | 772.57M | 1.71B | 0.3009 |
![]()
CRWD
Crowdstrike Holdings Inc
|
508.61 | 123.89B | 4.34B | -298.19M | 1.04B | -1.1966 |
![]()
SNPS
Synopsys Inc
|
448.00 | 81.53B | 6.43B | 1.15B | 1.30B | 12.77 |
Zscaler Inc Stock (ZS) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Sep-03-25 | Reiterated | BMO Capital Markets | Outperform |
Sep-02-25 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
Aug-26-25 | Initiated | B. Riley Securities | Neutral |
Jun-13-25 | Upgrade | Wells Fargo | Equal Weight → Overweight |
May-30-25 | Downgrade | Piper Sandler | Overweight → Neutral |
Apr-28-25 | Upgrade | Exane BNP Paribas | Neutral → Outperform |
Apr-23-25 | Initiated | Roth Capital | Neutral |
Apr-03-25 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
Apr-01-25 | Initiated | Stephens | Overweight |
Mar-18-25 | Resumed | Morgan Stanley | Equal-Weight |
Mar-07-25 | Upgrade | BofA Securities | Neutral → Buy |
Mar-06-25 | Reiterated | BMO Capital Markets | Outperform |
Mar-06-25 | Upgrade | Rosenblatt | Neutral → Buy |
Dec-03-24 | Reiterated | BMO Capital Markets | Outperform |
Oct-08-24 | Initiated | Exane BNP Paribas | Neutral |
Sep-04-24 | Reiterated | BMO Capital Markets | Outperform |
Sep-04-24 | Downgrade | BofA Securities | Buy → Neutral |
Jul-23-24 | Initiated | Raymond James | Mkt Perform |
Jul-16-24 | Downgrade | Mizuho | Outperform → Neutral |
Jun-14-24 | Reiterated | BMO Capital Markets | Outperform |
Jun-14-24 | Upgrade | JP Morgan | Neutral → Overweight |
May-28-24 | Downgrade | Rosenblatt | Buy → Neutral |
May-28-24 | Downgrade | Wells Fargo | Overweight → Equal Weight |
Apr-18-24 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
Jan-18-24 | Initiated | Bernstein | Outperform |
Jan-17-24 | Initiated | KeyBanc Capital Markets | Sector Weight |
Jan-03-24 | Reiterated | Oppenheimer | Outperform |
Dec-15-23 | Initiated | Susquehanna | Positive |
Dec-12-23 | Upgrade | Macquarie | Neutral → Outperform |
Nov-28-23 | Reiterated | Needham | Strong Buy |
Oct-19-23 | Upgrade | Jefferies | Hold → Buy |
Oct-09-23 | Upgrade | Barclays | Equal Weight → Overweight |
Oct-02-23 | Upgrade | Piper Sandler | Neutral → Overweight |
Jul-25-23 | Upgrade | BTIG Research | Neutral → Buy |
Jun-08-23 | Initiated | Oppenheimer | Outperform |
May-02-23 | Initiated | Rosenblatt | Buy |
Mar-17-23 | Initiated | CapitalOne | Equal Weight |
Feb-14-23 | Initiated | Goldman | Neutral |
Jan-24-23 | Initiated | JP Morgan | Neutral |
Jan-18-23 | Initiated | Scotiabank | Sector Outperform |
Jan-17-23 | Downgrade | Guggenheim | Buy → Neutral |
Jan-12-23 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
Dec-01-22 | Initiated | Redburn | Neutral |
Nov-02-22 | Initiated | Macquarie | Neutral |
Oct-21-22 | Initiated | Cantor Fitzgerald | Neutral |
Oct-19-22 | Resumed | Robert W. Baird | Outperform |
Oct-07-22 | Initiated | SMBC Nikko | Outperform |
Oct-06-22 | Initiated | Evercore ISI | Outperform |
Sep-22-22 | Initiated | MoffettNathanson | Hold |
Sep-16-22 | Initiated | MKM Partners | Buy |
Sep-15-22 | Initiated | Jefferies | Hold |
Aug-12-22 | Initiated | Guggenheim | Buy |
Jul-26-22 | Downgrade | BTIG Research | Buy → Neutral |
May-26-22 | Initiated | Stephens | Overweight |
Mar-02-22 | Upgrade | Daiwa Securities | Underperform → Buy |
Feb-25-22 | Reiterated | BMO Capital Markets | Outperform |
Feb-25-22 | Reiterated | BTIG Research | Buy |
Feb-25-22 | Reiterated | BofA Securities | Buy |
Feb-25-22 | Reiterated | Deutsche Bank | Buy |
Feb-25-22 | Reiterated | FBN Securities | Outperform |
Feb-25-22 | Reiterated | JP Morgan | Underweight |
Feb-25-22 | Reiterated | Mizuho | Buy |
Feb-25-22 | Reiterated | RBC Capital Mkts | Outperform |
Feb-25-22 | Reiterated | Robert W. Baird | Outperform |
Feb-25-22 | Reiterated | Stifel | Buy |
Feb-25-22 | Reiterated | UBS | Buy |
Feb-25-22 | Reiterated | Wedbush | Outperform |
Feb-25-22 | Reiterated | Wells Fargo | Overweight |
Feb-25-22 | Reiterated | Wolfe Research | Outperform |
Feb-22-22 | Resumed | JMP Securities | Mkt Outperform |
Jan-25-22 | Initiated | Citigroup | Buy |
Jan-21-22 | Initiated | Stifel | Buy |
Jan-18-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
Jan-10-22 | Upgrade | UBS | Neutral → Buy |
Jan-06-22 | Initiated | Wells Fargo | Overweight |
Dec-14-21 | Downgrade | JP Morgan | Neutral → Underweight |
Dec-06-21 | Downgrade | Daiwa Securities | Neutral → Underperform |
Nov-16-21 | Initiated | Credit Suisse | Outperform |
Sep-30-21 | Initiated | Daiwa Securities | Neutral |
Sep-10-21 | Reiterated | BMO Capital Markets | Outperform |
Sep-10-21 | Reiterated | BTIG Research | Buy |
Sep-10-21 | Reiterated | BofA Securities | Buy |
Sep-10-21 | Reiterated | Canaccord Genuity | Buy |
Sep-10-21 | Reiterated | Cowen | Outperform |
Sep-10-21 | Reiterated | Deutsche Bank | Buy |
Sep-10-21 | Reiterated | Mizuho | Buy |
Sep-10-21 | Reiterated | Morgan Stanley | Equal-Weight |
Sep-10-21 | Reiterated | Piper Sandler | Neutral |
Sep-10-21 | Reiterated | RBC Capital Mkts | Outperform |
Sep-10-21 | Reiterated | UBS | Neutral |
Aug-06-21 | Initiated | Wolfe Research | Outperform |
Jul-26-21 | Downgrade | Loop Capital | Buy → Hold |
Jul-15-21 | Reiterated | Canaccord Genuity | Buy |
May-27-21 | Initiated | Cowen | Outperform |
May-26-21 | Upgrade | BMO Capital Markets | Market Perform → Outperform |
Apr-13-21 | Initiated | Mizuho | Buy |
Mar-24-21 | Upgrade | Truist | Hold → Buy |
Mar-16-21 | Resumed | Credit Suisse | Outperform |
Mar-05-21 | Upgrade | Berenberg | Hold → Buy |
Feb-26-21 | Upgrade | BTIG Research | Neutral → Buy |
Feb-16-21 | Initiated | Canaccord Genuity | Buy |
Jan-20-21 | Initiated | JMP Securities | Mkt Outperform |
Jan-12-21 | Reiterated | Needham | Strong Buy |
Dec-10-20 | Downgrade | JP Morgan | Overweight → Neutral |
Dec-10-20 | Reiterated | Needham | Strong Buy |
Nov-25-20 | Upgrade | Credit Suisse | Neutral → Outperform |
Oct-26-20 | Initiated | JP Morgan | Overweight |
Aug-21-20 | Initiated | Loop Capital | Buy |
Aug-20-20 | Initiated | Deutsche Bank | Buy |
Jul-09-20 | Upgrade | Citigroup | Neutral → Buy |
Jul-06-20 | Initiated | RBC Capital Mkts | Outperform |
Jun-22-20 | Reiterated | Needham | Strong Buy |
Jun-18-20 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
Jun-16-20 | Downgrade | Berenberg | Buy → Hold |
May-29-20 | Reiterated | BofA/Merrill | Buy |
May-29-20 | Reiterated | Cowen | Outperform |
May-29-20 | Reiterated | Credit Suisse | Neutral |
May-29-20 | Reiterated | Needham | Strong Buy |
May-29-20 | Reiterated | Robert W. Baird | Outperform |
May-29-20 | Reiterated | Rosenblatt | Buy |
May-29-20 | Reiterated | UBS | Neutral |
May-29-20 | Reiterated | Wedbush | Outperform |
Apr-24-20 | Downgrade | SunTrust | Buy → Hold |
View All
Zscaler Inc Stock (ZS) Latest News
How to use Fibonacci retracement on Zscaler Inc.Quarterly Performance Summary & Smart Allocation Stock Tips - newser.com
Why Zscaler Inc. stock is favored by top institutionsIPO Watch & Weekly Top Stock Performers List - newser.com
Best data tools to analyze Zscaler Inc. stockWeekly Profit Report & Consistent Return Strategy Ideas - newser.com
Custom watchlist performance reports with Zscaler Inc.Portfolio Performance Report & Reliable Entry Point Trade Alerts - newser.com
Risk vs reward if holding onto Zscaler Inc.Market Performance Recap & Fast Gaining Stock Strategy Reports - newser.com
Is Zscaler Inc. stock trading at a premium valuation2025 Short Interest & Community Verified Trade Signals - newser.com
Is Zscaler Inc. stock a buy before product launches2025 Price Action Summary & Real-Time Price Movement Reports - newser.com
Why Zscaler Inc. (0ZC) stock attracts HNW investorsEarnings Overview Summary & Weekly High Return Opportunities - newser.com
Zscaler (ZS) Sponsors Healthcare Zero Trust Model: A Game Changer for Cybersecurity Leadership? - simplywall.st
What Zscaler (ZS)'s Role in Developing a Healthcare Cybersecurity Framework Means for Shareholders - Yahoo Finance
Zscaler stock reaches 52-week high at 319.68 USD - Investing.com
Zscaler stock reaches 52-week high at 319.68 USD By Investing.com - Investing.com Australia
Live market analysis of Zscaler Inc.Weekly Gains Report & Safe Capital Growth Trade Ideas - newser.com
Zscaler Stock Soars 7.22%, Hits Intraday High of $315.00 - Markets Mojo
Palo Alto Networks Rises 19.5% YTD: Time to Hold or Book Profits? - The Globe and Mail
Zscaler Inc. recovery potential after sell offJuly 2025 Reactions & Technical Pattern Alert System - newser.com
Can a trend reversal in Zscaler Inc. lead to recoveryJuly 2025 Action & Risk Controlled Stock Alerts - newser.com
Zscaler Inc Stock Analysis and ForecastGlobal Market Influence & Access Risk Ratings for Every Stock - earlytimes.in
Key Metrics Every Investor Should Know About Global Health Limited - earlytimes.in
Zscaler Stock Hits Day Low of $287.74 Amid Price Pressure - Markets Mojo
Zscaler, café-inspired branch networks, and mobile security - Network World
Here's Why Zscaler (ZS) Fell More Than Broader Market - sharewise.com
Workday, BILL, Workiva, Zscaler, and Snowflake Stocks Trade Down, What You Need To Know - The Globe and Mail
A Closer Look at Zscaler's Options Market Dynamics - Benzinga
Zscaler, Inc. (ZS) is Attracting Investor Attention: Here is What You Should Know - Yahoo
Security leaders at Okta and Zscaler share lessons from Salesloft Drift attacks - CyberScoop
Measuring Zscaler Inc.’s beta against major indicesQuarterly Growth Report & Detailed Earnings Play Alerts - newser.com
Zscaler (ZS): Evaluating Valuation Following Strong Q4 Results and Upbeat Fiscal 2026 Guidance - simplywall.st
Zscaler: Agent-To-Agent Security Is Coming, But Is It Priced In (NASDAQ:ZS) - Seeking Alpha
Can momentum traders help lift Zscaler Inc.Weekly Trend Report & Intraday High Probability Setup Alerts - newser.com
Predicting Zscaler Inc. trend using moving averages2025 Momentum Check & Technical Pattern Recognition Alerts - newser.com
Smart tools for monitoring Zscaler Inc.’s price actionQuarterly Earnings Summary & Weekly Watchlist for Hot Stocks - newser.com
What’s next for Zscaler Inc. stock priceQuarterly Trade Report & Step-by-Step Swing Trade Plans - newser.com
Zscaler: Why I'm Doubling Down Now - Seeking Alpha
Zscaler Stock Prediction: Where Analysts See the Stock Going by 2028 - TIKR.com
Zscaler: Unstoppable Momentum As ARR Builds (NASDAQ:ZS) - Seeking Alpha
Zscaler (NASDAQ:ZS) Upgraded at Zacks Research - Defense World
At US$305, Is Zscaler, Inc. (NASDAQ:ZS) Worth Looking At Closely? - 富途牛牛
Is Zscaler Inc 0ZC a good long term investmentAI-Driven Market Analysis & Beat the Market with AI Reports - earlytimes.in
Build Secure Generative AI Solutions with AWS and Zscaler - Amazon Web Services
How to monitor Zscaler Inc. with trend dashboardsWeekly Profit Analysis & Smart Allocation Stock Reports - newser.com
Will Zscaler’s (ZS) Push into Healthcare Zero Trust Redefine Its Competitive Edge? - simplywall.st
Zscaler’s Strong Market Position and Growth Potential Justify Buy Rating - TipRanks
Zscaler (ZS) Receives a Buy from RBC Capital - The Globe and Mail
Zscaler Inc Stock (ZS) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):